CN1328271C - Method for synthesizing beta-iodobutyl lactone - Google Patents
Method for synthesizing beta-iodobutyl lactone Download PDFInfo
- Publication number
- CN1328271C CN1328271C CNB2005100501877A CN200510050187A CN1328271C CN 1328271 C CN1328271 C CN 1328271C CN B2005100501877 A CNB2005100501877 A CN B2005100501877A CN 200510050187 A CN200510050187 A CN 200510050187A CN 1328271 C CN1328271 C CN 1328271C
- Authority
- CN
- China
- Prior art keywords
- iodine
- lactone
- beta
- iodobutyl
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to beta-iodo-butenolide and a synthetic method thereof which synthesizes the beta-iodo-butenolide from iodine and 2, 3-allenoic ester iodo-lactone by cyclization reaction in mixed solvent of water and organic solvent, namely that iodine and 2, 3-allenoic ester are cyclized in the mixed solvent of water and organic solvent under the condition of room temperature to prepare the beta-iodo-butenolide. The method has the advantages of mild reaction condition, short reaction time, high yield, low cost and easy industrialization and is suitable for various kinds of substituted allenoic ester.
Description
Technical field
The present invention relates to a kind of method of synthetic beta-iodobutyl lactone, be specifically related to a kind of by iodine participate in 2, the synthetic beta-iodobutyl lactone method of 3-connection olefin(e) acid ester cyclization.
Background technology
The five-membered ring unsaturated lactone is one of modal structural unit in the natural product, has multiple important physical activity.For example: antisepsis and anti-inflammation, antimycotic, antitumor and adjusting seed germination and plant-growth etc. have huge value of exploiting and utilizing at aspects such as medicine and agricultural chemicals.Beta-iodobutyl lactone is the synthetic above-mentioned very important intermediate of physiologically active compound that has.The traditional synthetic method of beta-iodobutyl lactone is by 2, and the iodo cyclization of 3-connection olefin(e) acid is synthetic, as document Tetrahedron Lett.1985,26,4811; Tetrahedron 1999,55, reported with iodine and 2 in 12137, and 3-connection olefine acid reaction prepares the method for beta-iodobutyl lactone.But because 2,3-connection olefin(e) acid be under acid or base catalysis by 2,3-connection olefin(e) acid ester hydrolysis and coming, under this condition, 2, the easy isomery of 3-connection olefin(e) acid ester turns to alkynes or generates other by product, makes the hydrolysis productive rate not high.Therefore the efficient succinct synthetic method of seeking this compounds is the focus of people's common concern always.People lay siege to by 2, the direct and iodine generation iodo lactone cyclization one-step synthesis beta-iodobutyl lactone of 3-connection olefin(e) acid ester.We are on the basis of document, by methodological a kind of reaction conditions gentleness, reaction times weak point, the method for synthetic this compounds that productive rate is high discovered.
Summary of the invention
At the deficiencies in the prior art, purpose of the present invention just provides a kind of by 2 of iodine participation, the method for the synthetic beta-iodobutyl lactone of 3-connection olefin(e) acid ester cyclization, and reaction formula is as follows:
R
1, R
2, R
3=H, alkyl or aryl, wherein alkyl is C
nH
2n+1(n=1-7) or benzyl, aryl is phenyl or naphthyl and contains substituent above-mentioned group.
The present invention is achieved by the following scheme, and the invention provides a kind of method of synthetic beta-iodobutyl lactone, comprises the following steps:
(1) in container, adds entry, organic solvent and, 3-connection olefin(e) acid ester as shown in the formula 2 shown in (I);
(2) with step (1) gained solution stirring, under agitation add iodine, at room temperature continued then stirring reaction 0.5-24 hour;
(3) in step (2) gained reaction solution, add shrend and go out, add saturated sodium thiosulfate and eliminate excessive iodine;
(4) separate desired product and purifying;
In the formula (I): R
1, R
2, R
3=H, alkyl or aryl, wherein alkyl is benzyl or C
nH
2n+1, n=1~7, aryl is phenyl or naphthyl or contains substituent above-mentioned group.
As a kind of improvement of the present invention, described organic solvent is methyl alcohol, ethanol, propyl alcohol, acetonitrile, acetone, dioxane or N, dinethylformamide.
As a kind of improvement of the present invention, described iodine and 2, the mol ratio of 3-connection olefin(e) acid ester is 3~1.
As a kind of improvement of the present invention, described iodine and 2, the mol ratio of 3-connection olefin(e) acid ester is 2.
The productive rate of the corresponding beta-iodobutyl lactone of present method gained is 65-91%.
The present invention has overcome the drawback of traditional method, has the following advantages: 1) reaction does not need anhydrous and oxygen-free, uses water-containing solvent to be reaction medium, environmental friendliness; 2) reaction conditions gentleness, at room temperature reaction, the reaction times is short, and the productive rate height is applicable to the connection olefin(e) acid ester of various replacements; 3) product is single, easily separated purifying; 4) conversion unit is simple, and cost is low, is easy to industrialization.
With iodine and 2, this compounds of 3-connection olefin(e) acid ester prepared in reaction beta-iodobutyl lactone does not appear in the newspapers as yet on the document.Owing to more active at transition metal-catalyzed alkene iodine key bebeerilene bromine key down or alkene chlorine key, easier generation linked reaction, thus composite structure is more complicated, the butenolide cyclic cpds that substituting group is abundanter.
Embodiment
Below in conjunction with specific embodiment the present invention is described in further detail.
Embodiment 1
In 25mL egg type bottle, add 2, and 3-heptadienoic acid ethyl ester (81.9mg, 0.53mmol), MeCN (4mL), water (0.27mL), (254mg 1.0mmol), continues stirring at room reaction 12 hours to add iodine under stirring.Add entry (6mL) cancellation in reaction solution, saturated sodium thiosulfate is eliminated excessive iodine.Use extracted with diethyl ether, anhydrous sodium sulfate drying filters, and concentrates, and rapid column chromatography gets product 3-iodo-γ-heptenoic acid lactone 94.9mg, and productive rate is 71%.Product is a white solid, and its fusing point is 57-58 ℃.
1H?NMR(400?MHz,CDCl
3)δ6.45(s,1H),4.89-4.92(m,1H),1.67-1.98(m,1H),1.50-1.55(m,1H),1.35-1.42(m,2H),0.91(t,J=6?Hz,3H);
13C?NMR(100?MHz,CDCl
3)δ171.1,129.9,125.5,87.9,34.6,17.3,13.7;
MS(70eV,EI)m/z(%):253(M
++1,100);
IR(KBr)v(cm
-1)1738,1582,1296,1168。
Embodiment 2
In 25mL egg type bottle, add 2, and 3-heptadienoic acid ethyl ester (81.4mg, 0.52mmol), MeCN (4mL), water (0.27mL), (381.8mg 1.5mmol), continues stirring at room reaction 12 hours to add iodine under stirring.All the other get product 3-iodo-γ-heptenoic acid lactone 94.7mg with embodiment 1, and productive rate is 71%.Product is a white solid, and its fusing point is 57-58 ℃.
Embodiment 3
In 25mL egg type bottle, add 2, and 3-heptadienoic acid ethyl ester (81.3mg, 0.52mmol), MeCN (4mL), water (0.27mL), (129.2mg 0.5mmol), continues stirring at room reaction 12 hours to add iodine under stirring.All the other get product 3-iodo-γ-heptenoic acid lactone 88.2mg with embodiment 1, and productive rate is 66%.Product is a white solid, and its fusing point is 57-58 ℃.
Embodiment 4
In 25mL egg type bottle, add 2, and 3-octadienoic acid ethyl ester (84.6mg, 0.5mmol), MeCN (4mL), water (0.27mL), (256.7mg 1.0mmol), continues stirring at room reaction 12 hours to add iodine under stirring.All the other get product 3-iodo-γ-octylenic acid lactone 86.4mg with embodiment 1, and productive rate is 65%.Product is a white solid, and its fusing point is 61-62 ℃.
1H?NMR(400?MHz,CDCl
3)δ6.52(s,1H),4.96-4.98(m,1H),2.02-2.08(m,1H),1.58-1.64(m,1H),1.37-1.42(m,4H),0.92(t,J=8Hz,3H);
13C?NMR(100?MHz,CDCl
3)δ171.2,130.0,125.5,88.0,32.2,25.7,22.3,13.8。
Embodiment 5
In 25mL egg type bottle, add 2, and 3-11 diolefinic acid ethyl esters (63.6mg, 0.3mmol), MeCN (4mL), water (0.27mL), (152.4mg 0.6mmol), continues stirring at room reaction 12 hours to add iodine under stirring.All the other get product 3-iodo-γ-undecylenic acid lactone 63.4mg with embodiment 1, and productive rate is 69%.Product is a white solid, and its fusing point is 78-79 ℃.
1H?NMR(400?MHz,CDCl
3)δ6.45(s,1H),4.89-4.91(m,1H),1.70-2.02(m,1H),1.49-1.56(m,1H),1.20-1.33(m,10H),0.82(t,J=6Hz,3H);
13C?NMR(100?MHZ,CDCl
3)δ171.2,130.0,125.5,88.0,32.5,31.7,29.1,29.0,23.7,22.6,14.1。
Embodiment 6
In 25mL egg type bottle, add 2-benzyl-2, and 3-heptadienoic acid ethyl ester (76.1mg, 0.31mmol), MeCN (4mL), water (0.27mL), (156mg 0.61mmol), continues stirring at room reaction 24 hours to add iodine under stirring.All the other get product 2-benzyl-3-iodo-γ-heptenoic acid lactone 82.4mg with embodiment 1, and productive rate is 78%.Product is a white solid, and its fusing point is 87-88 ℃.
1H?NMR(400?MHz,CDCl
3)δ7.12-7.25(m,5H),4.79-4.80(m,1H),3.53-3.61(m,2H),1.86-1.99(m,1H),1.42-1.47(m,1H),1.30-1.36(m,2H),0.85(t,J=8Hz,3H);
13C?NMR(100?Mz,CDCl
3)δ170.1,138.3,136.5,128.8,128.6,126.9,122.6,85.5,34.9,33.1,17.3,13.7;
MS(70eV,EI)m/z(100):342(M
+,15.71),129(100);
IR(KBr)v(cm
-1)1739,1633,1494,1451,1192;
Anal.Cacld.for?C
14H
15O
2I:C,49.14;H,4.42.Found:C,49.19;H,4.52。
Embodiment 7
In 25mL egg type bottle, add 2-benzyl-2, and 3-octadienoic acid ethyl ester (79.3mg, 0.31mmol), MeCN (4mL), water (0.27mL), add under stirring iodine (152.6mg, 0.6mmol), all the other get product 2-benzyl-3-iodo-γ-octylenic acid lactone 78.4mg with embodiment 1, and productive rate is 72%.Product is a white solid, and its fusing point is 92-93 ℃.
1H?NMR(400?MHz,CDCl
3)δ7.21-7.34(m,5H),4.78-4.80(d,1H),3.59(d,J=11.2Hz,1H),3.56(d,J=11.2Hz,1H),1.96-1.99(m,1H),1.49-1.53(m,1H),1.26(m,4H),0.81(t,J=5Hz,3H);
13C?NMR(100?MHz,CDCl
3)δ170.0,138.3,136.5,128.8,128.6,126.9,122.5,85.6,33.1,32.5,25.8,22.3,13.8;
MS(70eV,EI)m/z(100):357(M
++1,8.50),115(100);
IR(KBr)v(cm
-1)3029,1760,1635,1495,1061;
HRMS?Cacld.for?C
15H
17O
2I:356.02733.Found:356.02289。
Embodiment 8
In 25mL egg type bottle, add 2-methyl-2, and 3-heptadienoic acid ethyl ester (83.5mg, 0.5mmol), MeCN (4mL), water (0.27mL), add under stirring iodine (254.9mg, 1.0mmol), all the other get product 2-methyl-3-iodo-γ-heptenoic acid lactone 116.2mg with embodiment 1, and productive rate is 88%.Product is a white solid, and its fusing point is 63-65 ℃.
1H?NMR(400MHz,CDCl
3)δ?4.84-4.86(m,1H),1.96-2.02(m,1H),1.90(s,3H),1.50-1.53(m,1H),1.37-1.47(m,2H),0.93(t,J=8Hz,3H);
13C?NMR(100?MHz,CDCl
3)170.6,135.6,121.6,85.4,34.9,17.3,13.7,12.8;MS(70?eV,EI)m/z(%):266(M
+,14.05),139(100);
IR(KBr)v(cm
-1)1740,1639,1462,1275,1083,1010;
Anal.Cacld.for?C
8H
11O
2I:C,36.11;H,4.17.Found:C,36.13;H,4.36。
Embodiment 9
In 25mL egg type bottle, add 2-methyl-2, and 3-octadienoic acid ethyl ester (91.9mg, 0.5mmol), MeCN (4mL), water (0.27mL), add under stirring iodine (254mg, 1.0mmol), all the other get product 2-methyl-3-iodo-γ-octylenic acid lactone 125.3mg with embodiment 1, and productive rate is 89%.Product is a white solid, and its fusing point is 68-70 ℃.
1H?NMR(400?MHz,CDCl
3)δ4.87-4.89(m,1H),2.04-2.07(m,1H),1.93(s,3H),1.56-1.60(m,1H),1.33(m,4H),0.88-0.94(m,3H);
13C?NMR(100MHz,CDCl
3)170.5,135.7,121.6,85.5,34.4,25.8,22.3,13.9,12.8;IR(KBr)v(cm
-1)1739,1640,1466,1273,1088,1039;
MS(70eV,EI)m/z(%):281(M
++1,97.9),41(100);
Anal.Cacld.for?C
9H
13O
2I:C,38.59,H,4.68.Found:C,38.55,H,4.66。
Embodiment 10
In 25mL egg type bottle, add 2-methyl-2,3-11 diolefinic acid ethyl ester (88.2mg, 0.4mmol), MeCN (4mL), water (0.27mL) adds iodine (203.2mg under stirring, 0.8mmol), all the other get product 2-methyl-3-iodo-γ-undecylenic acid lactone 115.6mg with embodiment 1, and productive rate is 91%.Product is a white solid, and its fusing point is 83-84 ℃.
1H?NMR(400MHz,CDCl
3)δ4.84-4.88(m,1H),2.00-2.04(m,1H),1.91(s,3H),1.55-1.57(m,1H),1.25-1.34(m,10H),0.85-0.91(m,3H);
13C?NMR(100?MHz,CDCl
3)δ170.6,135.7,121.5,85.6,32.8,31.7,29.1,29.0,23.7,22.6,14.1,12.8;
MS(70eV,EI)m/z(%):322(M
++1,5.93),41(100);
IR(KBr)v(cm
-1)1735,1640,1276,1088;
Anal.Cacld.for?C
12H
19O
2I:C,44.74;H,5.94.Found:C,44.80;H,6.07。
Embodiment 11
In 25mL egg type bottle, add 2,4-dimethyl-2,3-pentadienoic acid ethyl ester (79.3mg, 0.51mmol), MeCN (4mL), water (0.27mL), add under stirring iodine (254mg, 1.0mmol), all the other are with embodiment 1, get product 2-methyl-3-iodo-4-methyl-γ-pentenoic acid lactone 99.7mg, productive rate is 77%.Product is a white solid, and its fusing point is 138-140 ℃.
1H?NMR(400?MHz,CDCl
3)δ1.89(s,3H),1.45(s,6H);
13C?NMR(100?MHz,CDCl
3)170.2,134.6,129.5,88.0,25.8,13.1;
IR(KBr)v(em
-1)1734,1640,1288,1080;
MS(70eV,EI)m/z(%):252(M
+,14.84),43(100)。
Embodiment 12
In 25mL egg type bottle, add 2-methyl-4-phenyl-2, and 3-divinyl acetoacetic ester (82.5mg, 0.41mmol), MeCN (4mL), water (0.27mL), (202.0mg 0.8mmol), continues stirring at room reaction 0.5 hour to add iodine under stirring.All the other get product 2-methyl-3-iodo-4 phenyl-γ-butenolide 102.1mg with embodiment 1, and productive rate is 83%.Product is a white solid, and its fusing point is 93-94 ℃.
1H?NMR(400?MHz,CDCl
3)δ7.40-7.42(m,3H),7.24-7.25(m,2H),5.75(s,1H),2.02(s,3H);
13C?NMR(100?MHz,CDCl
3)170.7,135.5,133.6,129.8,128.9,127.6,122.2,87.6,13.0。
Embodiment 13
In 25mL egg type bottle, add 2-propyl group-4-phenyl-2,3-divinyl acetoacetic ester (94.0mg, 0.40mmol), MeCN (4mL), water (0.27mL) adds iodine (206.8mg under stirring, 0.8mmol), all the other get product 2-propyl group-3-iodo-4 phenyl-γ-butenolide 125.5mg with embodiment 1, and productive rate is 94%.Product is a white solid, and its fusing point is 102-104 ℃.
1H?NMR(400MHz,CDCl
3)δ7.40-7.41(m,3H),7.22-7.24(m,2H),5.73(s,1H),2.40(t,J=7.2Hz,2H),1.63-1.69(m,2H),0.99(t,J=7.6Hz,3H);
13C?NMR(100MHz,CDCl
3)170.1,138.9,133.8,129.7,128.9,127.5,122.0,87.4,29.2,20.6,13.8;
IR(KBr)v(cm
-1)1758,1635,1493,1454;
MS(70eV,EI)m/z(%):328(M
+,6.17),105(100)。
Embodiment 14
In 25mL egg type bottle, add 2-benzyl-4-phenyl-2,3-divinyl acetoacetic ester (84.2mg, 0.30mmol), MeCN (4mL), water (0.27mL) adds iodine (153.9mg under stirring, 0.6mmol), all the other get product 2-benzyl-3-iodo-4 phenyl-γ-butenolide 91.9mg with embodiment 1, and productive rate is 81%.Product is a white solid, and its fusing point is 100-102 ℃.
1H?NMR(400MHz,CDCl
3)δ7.16-7.38(m,10H),5.72(s,1H),3.76(d,J=14.4Hz,1H),3.69(d,J=14.4Hz,1H);
13C?NMR(100MHz,CDCl
3)170.1,138.1,136.4,133.6,129.9,129.0,128.9,128.7,127.6,127.0,122.9,87.7,33.3;
IR(KBr)v(cm
-1)1761,1633,1602,1495,1455;
MS(70eV,EI)m/z(%):376(M
+,4.52),203(100);
HRMS?Calcd.for?C
17H
13O
2I:375.99603.Found:375.99608。
Embodiment 15
In 25mL egg type bottle, add 4-methyl-2, and 3-divinyl acetoacetic ester (71.2mg, 0.50mmol), MeCN (4mL), water (0.27mL), add under stirring iodine (257.4mg, 1.02mmol), all the other get product 3-iodo-4-methyl-γ-pentenoic acid lactone 71.0mg with embodiment 1, and productive rate is 60%.Product is a white solid, and its fusing point is 120-122 ℃.
1H?NMR(400MHz,CDCl
3)δ6.37(s,1H),1.47(s,6H);
13CNMR(400MHz,CDCl
3)170.4,133.2,129.1,90.5,25.54;
IR(KBr)v(cm
-1)1735,1584,1278,1246;
MS(70eV,EI)m/z(%):238(M
+,33.73),223(100);
HRMS?Calcd.for?C
6H
7O
2I:237.94908.Found:237.94925。
At last, it is also to be noted that what more than enumerate only is specific embodiments of the invention.Obviously, the invention is not restricted to above embodiment, many distortion can also be arranged.
The present invention can summarize with other the specific form without prejudice to spirit of the present invention and principal character.Therefore, no matter from which point, above-mentioned embodiment of the present invention all can only be thought can not limit the present invention to explanation of the present invention, claims have been pointed out scope of the present invention, and scope of the present invention is not pointed out in above-mentioned explanation, therefore, in implication suitable and any change in the scope, all should think to be included in the scope of claims with claims of the present invention.
Claims (4)
1, a kind of method of synthetic beta-iodobutyl lactone is characterized in that, comprises the following steps:
(1) in container, adds entry, organic solvent and, 3-connection olefin(e) acid ester as shown in the formula 2 shown in (I);
(2) with step (1) gained solution stirring, under agitation add iodine, at room temperature continued then stirring reaction 0.5-24 hour;
(3) in step (2) gained reaction solution, add shrend and go out, add saturated sodium thiosulfate and eliminate excessive iodine;
(4) separate desired product and purifying;
In the formula (I): R
1, R
2, R
3=H, alkyl or aryl, wherein alkyl is benzyl or C
nH
2n+1, n=1~7, aryl is phenyl or naphthyl or contains substituent above-mentioned group.
2, synthesize the method for beta-iodobutyl lactone according to claim 1, it is characterized in that described organic solvent is methyl alcohol, ethanol, propyl alcohol, acetonitrile, acetone, dioxane or N, dinethylformamide.
3, synthesize the method for beta-iodobutyl lactone according to claim 1, it is characterized in that, described iodine and 2, the mol ratio of 3-connection olefin(e) acid ester is 3~1.
4, synthesize the method for beta-iodobutyl lactone according to claim 1, it is characterized in that, described iodine and 2, the mol ratio of 3-connection olefin(e) acid ester is 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100501877A CN1328271C (en) | 2005-06-21 | 2005-06-21 | Method for synthesizing beta-iodobutyl lactone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100501877A CN1328271C (en) | 2005-06-21 | 2005-06-21 | Method for synthesizing beta-iodobutyl lactone |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1709883A CN1709883A (en) | 2005-12-21 |
CN1328271C true CN1328271C (en) | 2007-07-25 |
Family
ID=35706178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100501877A Expired - Fee Related CN1328271C (en) | 2005-06-21 | 2005-06-21 | Method for synthesizing beta-iodobutyl lactone |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1328271C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6848697B2 (en) * | 2016-06-30 | 2021-03-24 | 住友化学株式会社 | Method for manufacturing resist composition and resist pattern |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4010170A (en) * | 1975-09-24 | 1977-03-01 | Iowa State University Research Foundation, Inc. | Butenolide synthesis via carbonylation of vinylmercurials |
US5094681A (en) * | 1989-09-23 | 1992-03-10 | Bayer Aktiengesellschaft | Herbicidal 5h-furan-2-one derivatives |
WO1995005376A1 (en) * | 1993-08-19 | 1995-02-23 | Warner-Lambert Company | Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists |
CN1255495A (en) * | 1999-11-02 | 2000-06-07 | 中国科学院上海有机化学研究所 | Process for synthesizing beta-halobutenolide |
-
2005
- 2005-06-21 CN CNB2005100501877A patent/CN1328271C/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4010170A (en) * | 1975-09-24 | 1977-03-01 | Iowa State University Research Foundation, Inc. | Butenolide synthesis via carbonylation of vinylmercurials |
US4119642A (en) * | 1975-09-24 | 1978-10-10 | Iowa State University Research Foundation, Inc. | Butenolide synthesis via carbonylation of vinylmercurials in the presence of inorganic salts |
US5094681A (en) * | 1989-09-23 | 1992-03-10 | Bayer Aktiengesellschaft | Herbicidal 5h-furan-2-one derivatives |
WO1995005376A1 (en) * | 1993-08-19 | 1995-02-23 | Warner-Lambert Company | Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists |
CN1255495A (en) * | 1999-11-02 | 2000-06-07 | 中国科学院上海有机化学研究所 | Process for synthesizing beta-halobutenolide |
Also Published As
Publication number | Publication date |
---|---|
CN1709883A (en) | 2005-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wardrop et al. | π-Face selective azaspirocyclization of ω-(methoxyphenyl)-N-methoxyalkylamides | |
CN105330557A (en) | Preparation method of chiral alpha-amino acid | |
Harcken et al. | Total Syntheses of (−)‐Grandinolide and (−)‐Sapranthin by the Sharpless Asymmetric Dihydroxylation of Methyl trans‐3‐Pentenoate: Elucidation of the Stereostructure of (−)‐Sapranthin | |
CN109232311A (en) | A kind of Pregabalin synthetic method of green high-efficient | |
Saeed | Stereoselective Synthesis of (3R)‐3, 4‐Dihydro‐6, 8‐dimethoxy‐3‐undecyl‐1H‐[2] benzopyran‐1‐one and Derivatives, Metabolites from Ononis natrix | |
EP0004493B1 (en) | Ethers whose organic moieties have asymmetric atoms, methods for their preparation and their use for the resolution of alcohols, phenols or certain compounds with a lactone structure | |
CN1328271C (en) | Method for synthesizing beta-iodobutyl lactone | |
Das et al. | A mild, rapid and highly regioselective ring-opening of epoxides and aziridines with acetic anhydride under solvent-free conditions using ammonium-12-molybdophosphate | |
CN103402973B (en) | Compound and production method thereof, and for the production of the method for Ro 64-0796/002 | |
He et al. | Sharpless AD strategy towards the γ-methyl butenolide unit of acetogenins: Enantioselective synthesis of butenolide I and II with mosquito larvicidal activity | |
Genet | New asymmetric synthesis of β-hydroxy α-amino acids and analogues. Components of biologically active cyclopeptides | |
Primault et al. | Palladium-catalyzed benzylic-like nucleophilic substitution of benzofuran-, benzothiophene-and indole-based substrates by dimethyl malonate anion | |
Szechner | Synthesis and absolute configuration of two diastereoisomeric (1R, 2S, 3R)-and (1S, 2S, 3R)-2-amino-1-(2-furyl)-1, 3-butandiols | |
US10183923B2 (en) | Method for synthesizing a precursor of a single dairy-lactone isomer | |
CN101870670A (en) | Synthesis method of cyclobutylamine-2-carboxylic acid | |
Wang et al. | Catalytic enantioselective synthesis of optically active α-hydroxyl-β, γ-unsaturated acid esters as novel side chains of cerebrosides | |
Kido et al. | An asymmetric synthesis of carboxylic acid derivatives, including lactic acid and α-amino acid derivatives, from optically active 1-chlorovinyl p-tolyl sulfoxides and ester lithium enolates with creation of chirality at the α-position | |
Gündoğdu et al. | Reaction of (S)-homoserine lactone with Grignard reagents: synthesis of amino-keto-alcohols and β-amino acid derivatives | |
CN101265188A (en) | Method for preparing ethyl 2-oxy-4-phenylbutyrate | |
Vankar et al. | Asymmetric synthesis of chiral vinylic epoxides and α-hydroxy-β, γ-unsaturated esters via (−)-menthol based auxiliary and enzymatic resolution respectively | |
CN104230880A (en) | Simple preparation method of 2-((4R,6R)-6-aminoethyl-2,2-dimethyl-1,3-dioxyhexacyclo-4-yl)acetate | |
Haruna et al. | Asymmetric hydrogenation of furan-containing ketones over tartaric acid-modified Raney nickel catalyst | |
CN115716859B (en) | Preparation method of brain sterol intermediate cholest-5, 24-diene-3-acetate | |
Kim et al. | Facile preparation of α, β-unsaturated O, S-acetals and mixed acetals via 3-alkoxy-2-alkenylenesulfonium salts. | |
Zheng et al. | Asymmetric syntheses of the sex pheromones of pine sawflies, their homologs and stereoisomers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |